GSK2126458
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
GlaxoSmithKline
Overview
GSK2126458 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
GSK2126458 clinical trials
Explore related
Medical disclaimer. This page summarizes research about GSK2126458 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.